fluxd.news

Eli Lilly Says Experimental Diabetes Drug Shows Weight Loss Of 17% · fluxd.news

LIVE

Fintech

Eli Lilly Says Experimental Diabetes Drug Shows Weight Loss Of 17%

Benzinga·March 19, 2026 at 03:37 PM

Eli Lilly says retatrutide trial results show major weight loss and blood sugar improvements in the diabetes study.

Original Source

Benzinga — www.benzinga.com

Related in Fintech

OpenAI, Google refine AI commerce strategies
PYMNTS
Nevada bars Kalshi from offering event contracts
PYMNTS
Federal Reserve orders SVB collapse review
PYMNTS
Centralizing Treasury Operations Offers Key Benefits
PYMNTS